EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome

Mary Elizabeth Curtis, Tiffany Smith, Miroslav Nenov, Benjamin E Blass, Domenico Praticò

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-230205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Mary Elizabeth Curtis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Center at Temple, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retromer complex proteins are decreased in postmortem brain tissues from Down syndrome subjects and inversely correlate with the Alzheimer’s disease-like neuropathology. However, whether targeting in vivo the retromer system affects cognitive deficits and synaptic function in Down syndrome remains unknown.

Objective

The aim of the current study was to examine the effects of pharmacological retromer stabilization on cognitive and synaptic functions in a mouse model of Down syndrome.

Methods

Ts65dn mice were administered the pharmacological chaperone, TPT-172, or vehicle from 4 to 9 months of age and then assessed for changes in cognitive function. To assess the effects of TPT-172 on synaptic plasticity, hippocampal slices from Ts65dn mice were incubated in TPT-172 and used for field potential recordings.

Results

Chronic TPT-172 treatment improved performance in cognitive function tests, its incubation with hippocampal slices ameliorated synaptic function response.

Conclusion

Pharmacological stabilization of the retromer complex improves synaptic plasticity and memory in a mouse model of Down syndrome. These results support the therapeutic potential of pharmacological retromer stabilization for individual with Down syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeAlzheimer DiseaseMiceAnimalsMice, TransgenicCognitionNeuronal PlasticityHippocampusDisease Models, Animal

Stichwörter der Autor:innen

Alzheimer’s diseaseDown syndromeTs65dn miceretromer

Autor:innen und Institutionen

  • Alzheimer's Center at Temple, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • School of Pharmacy, Temple University, Philadelphia, PA, USA.

Zitieren

APA

Curtis, M. E., Smith, T., Nenov, M., Blass, B. E., & Praticò, D. (2023). Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-230205

Vancouver

Curtis ME, Smith T, Nenov M, Blass BE, Praticò D. Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-230205

BibTeX
@article{Curtis2023,
  author = {Curtis, Mary Elizabeth and Smith, Tiffany and Nenov, Miroslav and Blass, Benjamin E and Praticò, Domenico},
  title = {Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-230205}
}
Kostenlos starten →